Abstract
BackgroundOne reason patients with cancer cannot benefit from immunotherapy is the lack of immune cell infiltration in tumor tissues. Cancer-associated fibroblasts (CAFs) are emerging as central players in immune regulation...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have